Nevirapine and Gamma-glutamyltransferase increased - a phase IV clinical study of FDA data


Gamma-glutamyltransferase increased is found among people who take Nevirapine, especially for people who are male, 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Nevirapine and have Gamma-glutamyltransferase increased. It is created by eHealthMe based on reports of 11,611 people who have side effects when taking Nevirapine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 25, 2022

11,611 people reported to have side effects when taking Nevirapine.
Among them, 93 people (0.8%) have Gamma-glutamyltransferase increased.

What is Nevirapine?

Nevirapine has active ingredients of nevirapine. It is often used in hiv infection. eHealthMe is studying from 11,648 Nevirapine users for its effectiveness, alternative drugs and more.

What is Gamma-glutamyltransferase increased?

Gamma-glutamyltransferase increased is found to be associated with 2,039 drugs and 2,020 conditions by eHealthMe.

Number of Nevirapine and Gamma-glutamyltransferase increased reports submitted per year:

Could Nevirapine cause Gamma-glutamyltransferase increased?

Time on Nevirapine when people have Gamma-glutamyltransferase increased *:

  • < 1 month: 63.64 %
  • 1 - 6 months: 27.27 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 9.09 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Gamma-glutamyltransferase increased when taking Nevirapine *:

  • female: 28.4 %
  • male: 71.6 %

Age of people who have Gamma-glutamyltransferase increased when taking Nevirapine *:

  • 0-1: 3.03 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 7.58 %
  • 30-39: 33.33 %
  • 40-49: 33.33 %
  • 50-59: 21.21 %
  • 60+: 1.52 %

Common drugs people take besides Nevirapine *:

  1. Lamivudine: 27 people, 29.03%
  2. Stavudine: 27 people, 29.03%
  3. Kaletra: 15 people, 16.13%
  4. Didanosine: 13 people, 13.98%
  5. Zidovudine: 11 people, 11.83%
  6. Epivir: 10 people, 10.75%
  7. Ziagen: 10 people, 10.75%
  8. Norvir: 9 people, 9.68%
  9. Clarithromycin: 9 people, 9.68%
  10. Efavirenz: 8 people, 8.60%

Common side effects people have besides Gamma-glutamyltransferase increased *:

  1. Aspartate Aminotransferase Increased: 32 people, 34.41%
  2. Alanine Aminotransferase Increased: 31 people, 33.33%
  3. Blood Alkaline Phosphatase Increased: 22 people, 23.66%
  4. High Blood Cholesterol: 17 people, 18.28%
  5. Fever: 16 people, 17.20%
  6. Weight Decreased: 15 people, 16.13%
  7. Nausea (feeling of having an urge to vomit): 13 people, 13.98%
  8. Nausea And Vomiting: 11 people, 11.83%
  9. Blood Bilirubin Increased: 11 people, 11.83%
  10. Weakness: 10 people, 10.75%

Common conditions people have *:

  1. Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 16 people, 17.20%
  2. Insomnia (sleeplessness): 5 people, 5.38%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 4.30%
  4. Hepatitis C: 4 people, 4.30%
  5. Nausea (feeling of having an urge to vomit): 3 people, 3.23%
  6. Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 3 people, 3.23%
  7. High Blood Pressure: 3 people, 3.23%
  8. Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum): 2 people, 2.15%
  9. Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 2 people, 2.15%
  10. Pulmonary Tuberculosis (lungs tuberculosis): 1 person, 1.08%

* Approximation only. Some reports may have incomplete information.

Do you take Nevirapine and have Gamma-glutamyltransferase increased?

Check whether Gamma-glutamyltransferase increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Gamma-glutamyltransferase increased and when was it recovered:

Expand to all the drugs that have ingredients of nevirapine:

Alternative drugs to, pros and cons of Nevirapine:

Common Nevirapine side effects:

Browse all side effects of Nevirapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gamma-glutamyltransferase increased treatments and more:

COVID vaccines that are related to Gamma-glutamyltransferase increased:

Common drugs associated with Gamma-glutamyltransferase increased:

All the drugs that are associated with Gamma-glutamyltransferase increased:

Common conditions associated with Gamma-glutamyltransferase increased:

All the conditions that are associated with Gamma-glutamyltransferase increased:

How the study uses the data?

The study uses data from the FDA. It is based on nevirapine (the active ingredients of Nevirapine) and Nevirapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: